Figure 2

Comparison between CD4+ and CD8+ T cell numbers and CD4/CD8 ratio improvement in the 24 months following the start of cART in a population of HBcAb+  and HBcAb- HIV-positive subjects (A, B and C, respectively) and of HBcAb+  /HBsAb- and HBcAb+  /HBsAb + HIV-positive subjects (D, E and F, respectively).